{"version":"1.0","provider_name":"The Medical Xchange","provider_url":"https:\/\/themedicalxchange.com\/en\/","title":"Improving PPI Therapy: Current Obstacles and Opportunities - The Medical Xchange","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"xQcoBkYnBj\"><a href=\"https:\/\/themedicalxchange.com\/en\/2011\/10\/28\/american-college-of-gastroenterology-acg-2011\/\">Improving PPI Therapy: Current Obstacles and Opportunities<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/themedicalxchange.com\/en\/2011\/10\/28\/american-college-of-gastroenterology-acg-2011\/embed\/#?secret=xQcoBkYnBj\" width=\"600\" height=\"338\" title=\"&#8220;Improving PPI Therapy: Current Obstacles and Opportunities&#8221; &#8212; The Medical Xchange\" data-secret=\"xQcoBkYnBj\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/themedicalxchange.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2011\/10\/ACG_Slides_EN_Figure_1.PNG","thumbnail_width":960,"thumbnail_height":720,"description":"Washington, DC \u2013 For gastroesophageal reflux disease (GERD), relative acid control is the only meaningful variable for effective therapy. This concept has been blurred by studies that do not distinguish between the sources of upper gastrointestinal (GI) symptoms. Although it is true that pain or discomfort resembling GERD can be caused by other disorders, such as dysmotility, hypersensitivity, or functional diseases that may be driven by abnormal neurotransmitter signaling, the symptoms that stem from reflux of gastric contents into the lower esophagus are acid related in the vast majority of cases. New studies with strategies designed to increase the duration of acid control over each 24-hour dosing period repeat a message that has been restated by every advance which produced an improvement in acid control over the last several decades."}